The national manufacturers of the Republic of Kazakhstan in resolving problems of production of anti-tuberculosis pharmaceuticals


The article presents the possibilities of national manufacturers of pharmaceuticals to provide with medicines patients with tuberculosis in the Republic of Kazakhstan

Full Text

Restricted Access

About the authors

Larisa G. Sataeva

The S.D. Asfendiarov Kazakhskiy national medical university

050026, Almaty, the Republic of Kazakhstan
candidate of pharmaceutical sciences, assistant professor of chair of management and marketing in health care and pharmacy

S. E Kelimkhanova

The S.D. Asfendiarov Kazakhskiy national medical university

050026, Almaty, the Republic of Kazakhstan

R. Yu Garankina

The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia

310115, Moscow, Russia


  1. WHO. Global Tuberculosis control. WHO Report. Geneva; 2014.
  2. Сатаева Л.Г., Третьякова Д., Чекотаева К.А., Келимханова С.Е., Нурпеисова Л.С. Анализ возможностей фармацевтической промышленности Республики Казахстан в совершенствовании процесса лекарственного обеспечения в стране. МедиАль. 2015; (1): 261-2.



Abstract - 39

PDF (Russian) - 0


Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies